Iovance Biotherapeutics (IOVA) Cash from Financing Activities (2010 - 2026)
Iovance Biotherapeutics (IOVA) recorded Cash from Financing Activities of $49.29 million in Q2 2026, up 272.5% from $13.23 million a year earlier but down 47.8% from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Cash from Financing Activities (2010 - 2026) Analysis & Trends
On a TTM basis, Iovance Biotherapeutics' Cash from Financing Activities came in at $287.85 million as of Jun 30, 2026, up 43.3% year-over-year; for FY2025, it came in at $300.77 million, down 23.0% from FY2024.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of -12.2% (FY2020 to FY2025).
- Across earlier years, Cash from Financing Activities came in at $390.66 million in FY2024 (-15.6%), $462.96 million in FY2023 (+143.5%), $190.15 million in FY2022 (-20.5%) and $239.27 million in FY2021 (-58.5%).
- Quarterly Cash from Financing Activities has ranged from -$2.07 million in Q2 2022 to $258.17 million in Q1 2023 over the past five years.
- On a year-over-year basis, Cash from Financing Activities rose in three of the last seven quarters, with growth averaging 41.7%.
- Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 272.5% in Q2 2026, against a decline of 99.5% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $94.34 million (Q1 2026), $56.17 million (Q4 2025) and $88.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Iovance Biotherapeutics | 4.98 Bn | 3.77 Bn | 55.72 Mn | 49.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.29 Mn |
| Mar 31, 2026 | 94.34 Mn |
| Dec 31, 2025 | 56.17 Mn |
| Sep 30, 2025 | 88.06 Mn |
| Jun 30, 2025 | 13.23 Mn |
| Mar 31, 2025 | 143.32 Mn |
| Dec 31, 2024 | 2.31 Mn |
| Sep 30, 2024 | 41.95 Mn |
| Jun 30, 2024 | 152.83 Mn |
| Mar 31, 2024 | 193.58 Mn |
| Dec 31, 2023 | 962,000.00 |
| Sep 30, 2023 | 202.80 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 258.17 Mn |
| Dec 31, 2022 | 190.58 Mn |
| Sep 30, 2022 | 225,000.00 |
| Jun 30, 2022 | -2.07 Mn |
| Mar 31, 2022 | 1.42 Mn |
| Dec 31, 2021 | 4.15 Mn |
| Sep 30, 2021 | 20.77 Mn |
API Access
Iovance Biotherapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();